Adjunctive radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion
β Scribed by Weston Waxweiler; Justin R. Sigmon; Daniel J. Sheehan
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 54 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Perineural invasion is a feature associated with significantly poorer outcomes when present in cutaneous squamous cell carcinoma (CSCC). The incidence of this subset of CSCC continues to rise in the US, as does the confusion surrounding exactly how it should be managed. While management typically involves excision, considerable debate exists as to the appropriate use of adjuvant radiotherapy (ART) in addition to excision. This article reviews the current relevant evidence for the use of ART.
π SIMILAR VOLUMES
## Abstract ## __Background.__ Perineural invasion (PNI) in cutaneous squamous cell carcinoma of the head and neck (CSCCHN) is associated with decreased survival, particularly in patients with clinical signs of cranial nerve involvement. There is evidence to indicate that neural cell adhesion mole
## Abstract ## Background We retrospectively reviewed outcomes in patients treated with radiotherapy (RT) for cutaneous head and neck carcinoma with perineural invasion (PNI), with the aim of developing riskβadapted treatment guidelines. ## Methods A total of 118 patients were treated with RT be
## Abstract ## Objectives/Hypothesis: To discuss the role of radiotherapy (RT) in the treatment of cutaneous squamous and basal cell carcinomas of the head and neck. ## Methods: Review of the pertinent literature. ## Results: The likelihood of cure with a good cosmetic outcome is high for pati
## Background: Serine proteases have important roles in tumor invasion and metastasis, and their inhibitors, serine protease inhibitors (serpins), are attractive targets for therapeutic strategies. on chromosome 18q21, there is a cluster of serpins: maspin, headpin, and squamous cell carcinoma anti